Eli Lilly Defeats Bid To Nix Cancer Treatment Patent In France
A French judge has ruled that Eli Lilly's now-expired patent for a chemotherapy drug was valid at the time a rival's generic product infringed it, but refused to award the pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article